Urinary excretion of mevalonic acid as an indicator of cholesterol synthesis

Journal of Lipid Research

Volumn 37, Issue 10, 1996, Pages 2193-2201

  Lindenthal, Bernhard ^a   Simatupang, Abraham ^a   Dotti, Maria Teresa ^b   Federico, Antonio ^b   Lütjohann, Dieter ^a   Von Bergmann, Klaus ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

cholestyramine; diurna l variation of cholesterol synthesis; fecal balance; hypercholesterolemia; lovastatin; pravastatin; simvastatin; stable isotope

Indexed keywords

CHOLESTEROL; COLESTYRAMINE; CREATININE; MEVALONIC ACID; MEVINOLIN; PRAVASTATIN; SIMVASTATIN; STABLE ISOTOPE;

ADULT; AGED; ARTICLE; CEREBROTENDINOUS XANTHOMATOSIS; CHOLESTEROL SYNTHESIS; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; PRIORITY JOURNAL; URINALYSIS; URINARY EXCRETION; URINE LEVEL;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL; CHOLESTYRAMINE; CIRCADIAN RHYTHM; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LOVASTATIN; MALE; MEVALONIC ACID; MIDDLE AGED; PRAVASTATIN; REPRODUCIBILITY OF RESULTS; SIMVASTATIN; XANTHOMATOSIS, CEREBROTENDINOUS;

EID: 0029907802     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Goldstein, J. L., and M. S. Brown. 1990. Regulation of the mevalonate pathway. Nature. 343: 425-430.
2. Parker, T. S., D. J. McNamara, C. Brown, O. Garrigan, R. Kolb, H. Batwin, and E. H. Ahrens, Jr. 1982. Mevalonic acid in human plasma: relationship of concentration and circadian rhythm to cholesterol synthesis rates in man. Proc. Natl Acad. Sci. USA. 79: 3037-3041.
3. Parker, T. S., D. J. McNamara, C. D. Brown, R. Kolb, E. H. Ahrens, Jr., A. W. Alberts, J. Tobert, J. Chen, and P. J. De Schepper. 1984. Plasma mevalonate as a measure of cholesterol synthesis in man. J. Clin. Invest. 74: 795-804.
4. Popjak, G., G. Boehm, T. S. Parker, J. Edmond, P. A. Edwards, and A. M. Fogelman. 1979. Determination of mevalonate in blood plasma in man and rat. Mevalonate "tolerance" tests in man. J. Lipid Res. 20: 716-728.
5. Kopito, R. R., S. B. Weinstock, L. E. Freed, D. M. Murray, and H. Brunengraber. 1982. Metabolism of plasma mevalonate in rats and humans. J. Lipid Res. 23: 577-583.
6. Kopito, R. R., and H. Brunengraber. 1980. (R)-mevalonate excretion in human and rat urines. Proc. Natl. Acad. Sci. USA. 77: 5738-5740.
7. Jones, P. J., A. S. Pappu, D. R. Illingworth, and C. A. Leitch. 1992. Correspondence between plasma mevalonic acid levels and deuterium uptake in measuring human cholesterol synthesis. Eur. J. Clin. Invest. 22: 609-613.
8. Capuzzi, D. M., and W. H. Cevallos. 1984. Inhibition of hepatic cholesterol and triglyceride synthesis by guanabenz acetate. J. Cardiovasc. Pharmacol. 6 Suppl 5: S847-52.
9. Pappu, A. S., and D. R. Illingworth. 1989. Contrasting effects of lovastatin and cholestyramine on low-density lipoprotein cholesterol and 24-hour urinary mevalonate excretion in patients with heterozygous familial hypercholesterolemia. J. Lab. Clin. Med. 114: 554-562.
10. Salen, G., and S. M. Grundy. 1973. The metabolism of cholestanol, cholesterol, and bile acids in cerebrotendinous xanthomatosis. J. Clin. Invest. 52: 2822-2835.
11. Lindenthal, B., and K. von Bergmann. 1994. Determination of urinary mevalonic acid using isotope dilution technique. Biol. Mass. Spectrom. 23: 445-450.
12. Czubayko, F., B. Beumers, S. Lammsfuss, D. Lütjohann, and K. von Bergmann. 1991. A simplified micro-method for quantification of fecal excretion of neutral and acidic sterols for outpatient studies in humans. J. Lipid Res. 32: 1861-1867.
13. Souci, S. W., W. Fachmann, and H. Kraut. 1990. Composition and Nutrition Tables 1989/1990. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, Germany.
14. Friedewald, W. T., R. I. Levy, and D. S. Fredrickson. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502.
15. Lütjohann, D., I. Björkhem, U. F. Beil, and K. von Bergmann. 1995. Sterol absorption and sterol balance in phytosterolemia evaluated by deuterium-labeled sterols: effect of sitostanol treatment. J. Lipid Res. 36: 1763-1773.
16. Bloch, K. 1965. The biological synthesis of cholesterol. Science. 150: 19-28.
17. Stacpoole, P. W., K. von Bergmann, L. L. Kilgore, L. A. Zech, and W. R. Fisher. 1991. Nutritional regulation of cholesterol synthesis and apolipoprotein B kinetics: studies in patients with familial hypercholesterolemia and normal subjects treated with a high carbohydrate, low fat diet. J. Lipid Res. 32: 1837-1848.
18. Tangedahl, T. N., A. F. Hofmann, and B. A. Kottke. 1979. Biliary lipid secretion in hypercholesterolemia. J. Lipid Res. 20: 125-133.
19. Leiss, O., K. Meyer-Krahmer, and K. von Bergmann. 1986. Biliary lipid secretion in patients with heterozygous familial hypercholesterolemia and combined hyperlipidemia. Influence of bezafibrate and fenofibrate. J. Lipid Res. 27: 713-723.
20. Grundy, S. M., E. H. Ahrens, Jr., and T. A. Miettinen. 1965. Quantitative isolation and gas-liquid chromatography analysis of total fecal bile acids. J. Lipid Res. 6: 397-410.
21. Miettinen, T. A., E. H. Ahrens, Jr., and S. M. Grundy. 1965. Quantitative isolation and gas-liquid Chromatographic analysis of total dietary and fecal neutral sterols. J. Lipid Res. 6: 411-424.
22. Kempen, H. J. M., F. C. Glatz, J. A. Gevers Leuven, H. A. van der Voort, and B. M. Katan. 1988. Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. J. Lipid Res. 29: 1149-1155.
23. Duane, W. C. 1995. Serum lathosterol levels in human subjects reflect changes in whole body cholesterol synthesis induced by lovastatin but not dietary cholesterol. J. Lipid Res. 36: 343-348.
24. Wolthers, B. G., H. T. Walrecht, J. C. van der Molen, G. T. Nagel, J. J. van Doormaal, and P. N. Wijnandts. 1991. Use of determinations of 7-lathosterol (5α-cholest-7-en3β-ol) and other cholesterol precursors in serum in the study and treatment of disturbances of sterol metabolism, particularly cerebrotendinous xanthomatosis. J. Lipid Res. 32: 603-612.
25. Nestel, P. J., H. M. Whyte, and D. W. S. Goodman. 1969. Distribution and turnover of cholesterol in humans. J. Clin. Invest. 48: 982-991.
26. Miettinen, T. A. 1971. Cholesterol production in obesity. Circulation. 44: 842-850.
27. Grundy, S. M., H. Y. I. Mok, and K. von Bergmann. 1976. Regulation of biliary cholesterol secretion in man. In The Liver. Quantitative Aspects of Structure and Function. R. Preisig, J. Bircher, and G. Paumgartner, editors. Editio Cantor, Aulendorf. 393-403.
28. Pappu, A. S., and D. R. Illingworth. 1994. Diurnal variations in the plasma concentrations of mevalonic acid in patients with abetalipoproteinemia. Eur. J. Clin. Invest. 24: 698-702.
29. Illingworth, D. R., W. E. Connor, D. S. Lin, and J. Diliberti. 1980. Lipid metabolism in abetalipoproteinemia: a study of cholesterol absorption and sterol balance in two patients. Gastroenterology. 78: 68-75.
30. Jones, P. J., and D. A. Schoeller. 1990. Evidence for diurnal periodicity in human cholesterol synthesis. J. Lipid Res. 31: 667-673.
31. Faix, D., R. Neese, C. Kletke, S. Wolden, M. Coutlangus, C. H. Shackleton, and M. K. Hellerstein. 1993. Quantification of menstrual and diurnal periodicities in rates of cholesterol and fat synthesis in humans. J. Lipid Res. 34: 2063-2075.
32. Pappu, A. S., D. R. Illingworth, and S. Bacon. 1989. Reduction in plasma low-density lipoprotein cholesterol and urinary mevalonic acid by lovastatin in patients with heterozygous familial hypercholesterolemia. Metabolism. 38: 542-549.
33. Beil, F. U., A. Schrameyer Wernecke, U. Beisiegel, H. Greten, J. D. Karkas, R. Liou, A. W. Alberts, H. G. Eckardt, and A. E. Till. 1990. Lovastatin versus bezafibrate: efficacy, tolerability, and effect on urinary mevalonate. Cardiology. 77 Suppl 4: 22-32.